GAMBIT Task for Post-Traumatic Stress Disorder
Study Summary
This trial will study the effects of a digital task called GAMBIT on brain circuits, behavior, and symptoms in people with PTSD.
- Post Traumatic Stress Disorder
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
What is the participant capacity for this clinical research?
"Affirmative. Information gathered from clinicaltrials.gov confirms that this experiment, which first appeared on October 1st 2022, is actively seeking individuals who meet the criteria to take part. The researchers are looking for 50 people at a single medical site."
Do I qualify for participation in this research study?
"Aspiring participants of this clinical trial should be between 18 and 55 years old, have an understanding of the English language sufficient to comprehend informed consent processes, meet diagnostic criteria for PTSD according to DSM-5 standards with a score of at least 30 on CAPS-5 exams, possess no prior history of any psychiatric disorder, yet must have experienced a civilian or non-civilian traumatic event. A total amount of 50 individuals will be accepted into this study."
Does this study accept participants that are younger than 40 years old?
"As per the instructions detailed in the inclusion criteria, individuals must be at least 18 years old and not exceed 55 to enroll."
Is it possible to sign up for this experiment at present?
"Indeed, clinicaltrials.gov displays information that this research project is recruiting individuals at the time of writing. This trial was first posted on October 1st 2022 and has since been updated as recently as October 17th 2022. In total, 50 participants need to be sourced from a single medical centre."
What is the desired outcome of this clinical research?
"The CAPS-5 score at Day 52 serves as the primary measurement for this clinical trial to evaluate its success. Secondary assessments, such as PCL-5 scores taken on day 23 and weekly during the first 6 weeks will also be used. Additionally, a final PCL-5 score is expected after Week 52."